Liraglutide biosimilar (PeptiGrowth)

利拉鲁肽生物类似药 (PeptiGrowth)

Report date: 2024/08/23 09:47:30

Base Information

Drug NameLiraglutide biosimilar (PeptiGrowth)

Drug Alias NameN/A

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionGlucagon-like peptide 1 receptor agonists

TargetsGlucagon-like peptide 1 receptor

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPeptiGrowth Inc

China Registration ClassN/A

Active CompaniesPeptiGrowth Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A